Showing 1 - 5 results of 5 for search 'Neil McAuslane', query time: 0.05s Refine Results
  1. 1
    A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

    A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines by Magdalena Bujar, Neil McAuslane, Stuart Walker, Sam Salek

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017-2018 using the OpERA methodology

    An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017-2018 using the OpERA methodology by Lawrence Liberti, Rian Marie Extavour, Prisha Patel, Neil McAuslane

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of Medicines

    The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of Medicines by Magdalena Bujar, Magdalena Bujar, Neil McAuslane, Stuart Walker, Stuart Walker, Sam Salek

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Companies' Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

    Companies' Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study by Ting Wang, Ting Wang, Neil McAuslane, Lawrence Liberti, Helga Gardarsdottir, Wim Goettsch, Wim Goettsch, Hubert Leufkens

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile

    Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile by Ting Wang, Ting Wang, Neil McAuslane, Wim G. Goettsch, Wim G. Goettsch, Hubert G. M. Leufkens, Marie L. De Bruin

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: